Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study.

Curr Med Res Opin 2018 01 21;34(1):49-54. Epub 2017 Nov 21.

w Breast Oncology Center, The Cancer Institute Hospital of JFCR , Tokyo , Japan.

Objective: The JBCRG-C06 Safari study showed that earlier fulvestrant 500 mg (F500) use, a longer time from diagnosis to F500 use, and no prior palliative chemotherapy were associated with significantly longer time to treatment failure (TTF) among Japanese patients with estrogen receptor-positive (ER+) advanced breast cancer (ABC). The objective of this sub-group analysis was to further examine data from the Safari study, focusing on ER + and human epidermal growth factor receptor-negative (HER2-) cases.

Methods: The Safari study (UMIN000015168) was a retrospective, multi-center cohort study, conducted in 1,072 patients in Japan taking F500 for ER + ABC. The sub-analysis included only patients administered F500 as second-line or later therapy (n = 960). Of these, 828 patients were HER2-. Results Multivariate analysis showed that advanced age (≥65 years; p = .035), longer time (≥3 years) from ABC diagnosis to F500 use (p < .001), no prior chemotherapy (p < .001), and F500 treatment line (p < .001) were correlated with prolonged TTF (median = 5.39 months).

Conclusions: In ER+/HER2- patients receiving F500 as a second-line or later therapy, treatment line, advanced age, no prior palliative chemotherapy use, and a longer period from ABC diagnosis to F500 use were associated with longer TTF.

Download full-text PDF

Source
http://dx.doi.org/10.1080/03007995.2017.1400426DOI Listing
January 2018
36 Reads

Publication Analysis

Top Keywords

safari study
16
longer time
12
treatment failure
8
advanced breast
8
fulvestrant 500 mg
8
breast cancer
8
sub-group analysis
8
time treatment
8
jbcrg-c06 safari
8
diagnosis f500
8
estrogen receptor-positive
8
study
5
patients
5
f500
5
study umin000015168
4
umin000015168 retrospective
4
multi-center cohort
4
conducted 1072
4
study conducted
4
cohort study
4

Similar Publications